Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
Myeloid Therapeutics
Normunity AccelCo, Inc.
NeoTX Therapeutics Ltd.
MacroGenics